IMTXW logo

Immatics N.V. Warrants


IMTXW: Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.


Show IMTXW Financials

Consumer Interest
SEC Filings

Recent trades of IMTXW by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by IMTXW's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of IMTXW in WallStreetBets Daily Discussion


Recent insights relating to IMTXW

CNBC Recommendations

Recent picks made for IMTXW stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in IMTXW

Corporate Flights

Flights by private jets registered to IMTXW